12/2017: Four projects successfully completed in Q4
Laronidase, Ipilimumab, Natalizumab, Pembrolizumab.
These 4 cell line development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now!
UGA Biopharma GmbH
16761 Hennigsdorf, Neuendorfstraße 20a (Germany)
Phone: +49 (0)3302 / 2024900
We call you back
Leave your name and phone number, we will call you back immediately